Abstract:RNAs play critical roles in diverse catalytic and regulatory biological processes and are emerging as important disease biomarkers and therapeutic targets. Thus, developing chemical compounds for targeting any desired RNA structures has great potential in biomedical applications. The viral and cellular RNA sequence and structure databases lay the groundwork for developing RNA-binding chemical ligands through the recognition of both RNA sequence and RNA structure. Influenza A virion consists of eight segments of negative-strand viral RNA (vRNA), all of which contain a highly conserved panhandle duplex structure formed between the first 13 nucleotides at the 5' end and the last 12 nucleotides at the 3' end. Here, we report our binding and cell culture anti-influenza assays of a short 10-mer chemically modified double-stranded RNA (dsRNA)-binding peptide nucleic acid (PNA) designed to bind to the panhandle duplex structure through novel major-groove PNA-RNA(2) triplex formation. We demonstrated that incorporation of chemically modified PNA residues thiopseudoisocytosine (L) and guanidine-modified 5-methyl cytosine (Q) previously developed by us facilitates the sequence-specific recognition of Watson-Crick G-C and C-G pairs, respectively, at physiologically relevant conditions. Significantly, the chemically modified dsRNA-binding PNA (dbPNA) shows selective binding to the dsRNA region in panhandle structure over a single-stranded RNA (ssRNA) and a dsDNA containing the same sequence. The panhandle structure is not accessible to traditional antisense DNA or RNA with a similar length. Conjugation of the dbPNA with an aminosugar neamine enhances the cellular uptake. We observed that 2-5 mu M dbPNA-neamine conjugate results in a significant reduction of viral replication. In addition, the 10-mer dbPNA inhibits innate immune receptor RIG-I binding to panhandle structure and thus RIG-I ATPase activity. These findings would provide the foundation for developing novel dbPNAs for the detection of influenza viral RNAs and therapeutics with optimal antiviral and immunomodulatory activities.

In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery

Inhibition of influenza A virus replication by RNA interference targeted against the PB1 subunit of the RNA polymerase gene

Effective Small Interfering RNAs Targeting Matrix and Nucleocapsid Protein Gene Inhibit Influenza A Virus Replication in Cells and Mice

Inhibition of Influenza Virus Production in Virus-Infected Mice by RNA Interference.

Inhibitory Effect of Small Interfering RNA Specific for a Novel Candidate Target in PB1 Gene of Influenza A Virus.

Construction of Influenza Virus Sirna Expression Vectors and Their Inhibitory Effects on Multiplication of Influenza Virus.

Polycation-mediated delivery of siRNAs for prophylaxis and treatment of influenza virus infection.

Rapid Identification of Small Interfering Rna That Can Effectively Inhibit the Replication of Multiple Influenza B Virus Strains

Inhibition of Influenza A Virus Replication by Short Hairpin RNA Expression Plasmid

RNA interference against influenza A (H1N1) virus

RNA Interference of Influenza Virus Production by Directly Targeting Mrna for Degradation and Indirectly Inhibiting All Viral RNA Transcription

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

Inhibition of Foot and Mouth Disease Virus Replication in Vitro and in Vivo by Dual Short Hairpin RNA-Mediated RNA Interference

Inhibition of highly pathogenic avian influenza virus (H5NI) production by small interfering RNA specific for the NP gene

Effective Inhibition of Mrna Accumulation and Protein Expression of H5N1 Avian Influenza Virus NS1 Gene in Vitro by Small Interfering RNAs

Inhibition of Avian Influenza Virus Replication Via Short Interfering RNA Expressed by Plasmid

A Short Chemically-Modified dsRNA-Binding PNA (dbPNA) Inhibits Influenza Viral Replication by Targeting Viral RNA Panhandle Structure.

RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.

Delivery System Targeting Hemagglutinin of Influenza Virus A to Facilitate Antisense-Based Anti-H1N1 Therapy.

Inhibition of Porcine Reproductive and Respiratory Syndrome Virus Replication by Adenovirus-Mediated RNA Interference Both in Porcine Alveolar Macrophages and Swine.

Inhibition of Severe Acute Respiratory Syndrome Virus Replication by Small Interfering RNAs in Mammalian Cells